首页> 外文期刊>Johnson Matthey Technology Review >Johnson Matthey Highlights: July 2016
【24h】

Johnson Matthey Highlights: July 2016

机译:庄信万丰亮点:2016年7月

获取原文
       

摘要

Total synthesis of the synthetic breast cancer drug Halaven involves stereocontrol of four centres and these were successfully derived from the聽D-quinic acid source. This allowed a crystallographic purification route in place of the chromatographic technique. It illustrates the first example of a crystallisation induced diastereoselective transformation of an 伪-methyl nitrile, as well as benefiting from the rigid bridged polycyclic system. The tangible benefits are an 80% reduction in cost and waste compared to the conventional route, largely due to the elimination of chromatography solvents, in accordance with green chemistry principles.
机译:合成乳腺癌药物Halaven的全合成涉及四个中心的立体控制,并且这些成功地源自D-奎宁酸来源。这允许晶体学纯化路线代替色谱技术。它说明了结晶诱导的α-甲基腈非对映选择性转化的第一个例子,以及得益于刚性桥联多环系统。与常规方法相比,明显的好处是成本和浪费减少了80%,这主要是因为根据绿色化学原理,消除了色谱溶剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号